AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Intersect ENT to Present at the 31st Annual Piper Jaffray Healthcare Conference

November 19, 2019

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 19, 2019--

Intersect ENT, Inc. (NASDAQ: XENT ) today announced that management will participate in the 31 st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City, and will present in a session at 4:30 pm ET.

A replay of the session will be available via the investors section of the company’s website at www.intersectENT.com. The webcast replay will be archived for approximately one month.

About Intersect ENT®

Intersect ENT is dedicated to transforming ear, nose and throat care by providing innovative, clinically meaningful therapies to physicians and patients. The company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.

For additional information on the company or its products, including risks and benefits, please visit www.IntersectENT.com.

XENT-F

View source version on businesswire.com:https://www.businesswire.com/news/home/20191119006025/en/

CONTACT: Jeri Hilleman

650.641.2105

ir@intersectENT.com

KEYWORD: CALIFORNIA NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH MEDICAL DEVICES

SOURCE: Intersect ENT, Inc.

Copyright Business Wire 2019.

PUB: 11/19/2019 04:05 PM/DISC: 11/19/2019 04:05 PM

http://www.businesswire.com/news/home/20191119006025/en